Fundraising Fox
Bluejay Diagnostics
NASDAQ: BJDXActon, US · Founded 2015 · Delaware corporation
Find your way into Bluejay Diagnostics
Sign up to see every warm intro you have to Bluejay Diagnostics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Bluejay Diagnostics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Bluejay Diagnostics develops the Symphony Suite, a near-patient diagnostic testing system that delivers medical test results in about 20 minutes, faster than traditional clinical chemistry labs. The products target healthcare settings inside and outside the lab to reduce wait times and support faster clinical decisions.
Founders & leadership
Bluejay Diagnostics was founded in 2015 by Indranil (Neil) Dey.
I(
Indranil (Neil) DeyPresident, Chief Executive Officer and Director
SD
Svetlana DeyExecutive
Board
DC
Donald ChaseBoard director
MM
Mirza MehdiBoard director
AL
Arthur LoomisBoard director
DW
Douglas WurthBoard director
Funding
SEC filings, press & company announcements$4.7M disclosed across 5 of 8 rounds · 2017–2026
- Undisclosed amountprivate placementJun 2026Source ↗
- Undisclosed amountPrivate Securities OfferingJun 2026Source ↗
▶$1MraisedJun 2021 · 1 investors · Other Health CareRule 506(b)
▶$1MraisedJun 2021 · 1 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Donald ChaseDirector
- Indranil DeyExecutive Officer, Director
- Svetlana DeyExecutive Officer, Director
- Mirza MedhiDirector
- Douglas WurthDirector
- Offering amount
- $1M
- Amount sold
- $1M
- First sale
- Oct 2020
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$154KraisedDec 2020 · 12 investors · Other Health CareRule 506(b)
▶$154KraisedDec 2020 · 12 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Indranil DeyExecutive Officer, Director
- Douglas WurthDirector
- Donald ChaseDirector
- Mirza MedhiDirector
- Arthur LoomisDirector
- Svetlana DeyExecutive Officer, Director
- Offering amount
- $154K
- Amount sold
- $154K
- First sale
- Oct 2020
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$115KraisedOct 2020 · 2 investors · Other Health CareRule 506(b)
▶$115KraisedOct 2020 · 2 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Svetlana DeyExecutive Officer, Director
- Indranil DeyExecutive Officer, Director
- Douglas WurthDirector
- Amman HaidriExecutive Officer
- Mirza MedhiDirector
- Arthur LoomisDirector
- Donald ChaseDirector
- Offering amount
- $115K
- Amount sold
- $115K
- First sale
- Aug 2020
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$1.6MraisedApr 2019 · 6 investors · Other Health CareRule 506(b)
▶$1.6MraisedApr 2019 · 6 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Amman HaidriExecutive Officer
- Arthur LoomisDirector
- Mirza MedhiDirector
- Donald ChaseDirector
- Douglas WurthDirector
- Svetlana DeyExecutive Officer, Director
- Indranil DeyExecutive Officer, Director
- Offering amount
- $1.6M
- Amount sold
- $1.6M
- First sale
- Apr 2019
- Incorporated
- Corporation, Delaware, 2015
- Federal exemptions
- 06b
▶$1.9MraisedApr 2017 · 9 investors · Other Health CareRule 506(b)
▶$1.9MraisedApr 2017 · 9 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Donald ChaseDirector
- Mirza MehdiDirector
- Arthur LoomisDirector
- Indranil DeyDirector
- Douglas WurthDirector
- Svetlana DeyExecutive Officer, Director
- Offering amount
- $2M
- Amount sold
- $1.9M
- Minimum investment
- $20K
- Sales commissions
- $136.6K
- Placement agents
- Northeast Capital
- First sale
- Mar 2017
- Incorporated
- Corporation, Delaware, 2015
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Related companies · 8
StockTwitsStocktwits operates an online community platform where investors and traders share ideas, analysis, and trade discussions organized around stock tickers. The page presented is its community guidelines rather than a product description.
TipRanksFinancial analysis and stock research platform.
BluejayBluejay develops tools for improving the reliability of generative AI systems in production environments. The company is focused on ensuring trust and dependability in real-world AI deployments.
Blue JBlue J is an AI-powered platform providing tax research and analysis tools for tax professionals and accountants across North America and the UK. The company uses generative AI to help navigate complex tax law and deliver clarity on tax regulations.
TradingViewTradingView is a charting platform and social network used by over 100 million traders and investors worldwide to analyze and trade across global financial markets. The platform provides tools for technical analysis, market data, and community collaboration for retail and institutional traders.
RobinhoodRobinhood is a financial trading platform that enables users to manage portfolios across stocks, ETFs, cryptocurrencies, options, futures, and prediction markets. The platform serves retail investors with low barriers to entry, offering portfolio management services and market insights.
Foresight DiagnosticsForesight Diagnostics develops ultra-sensitive molecular diagnostic tests that combine genomics and bioinformatics to detect minimal residual disease and circulating tumor DNA across multiple cancer types. Its offerings support oncology drug development, clinical trials, and patient care for academic and biopharma partners.
NasdaqNasdaq operates a technology infrastructure platform for financial markets across three business segments: Capital Access Platforms (which includes listing services, indices, and analytics tools), Financial Technology (comprising compliance, regulatory, and capital markets software), and Market Services (equities and derivatives trading operations). The company serves financial institutions, listed companies, investment managers, and regulatory agencies globally.
Companies working in the same space as Bluejay Diagnostics.
In the news
Frequently asked questions
- What does Bluejay Diagnostics do?
- Bluejay Diagnostics develops the Symphony Suite, a near-patient diagnostic testing system that delivers medical test results in about 20 minutes, faster than traditional clinical chemistry labs. The products target healthcare settings inside and outside the lab to reduce wait times and support faster clinical decisions.
- Who founded Bluejay Diagnostics?
- Bluejay Diagnostics was founded by Indranil (Neil) Dey in 2015.
- How much funding has Bluejay Diagnostics raised?
- Bluejay Diagnostics has disclosed $4.7M raised across 5 of its 8 known rounds.
- Where is Bluejay Diagnostics headquartered?
- Bluejay Diagnostics is headquartered in Acton, US.